Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 153

1.

Effects of Pioglitazone on Glucose-Dependent Insulinotropic Polypeptide-Mediated Insulin Secretion and Adipocyte Receptor Expression in Patients With Type 2 Diabetes.

Tharp WG, Gupta D, Sideleva O, Deacon CF, Holst JJ, Elahi D, Pratley RE.

Diabetes. 2020 Feb;69(2):146-157. doi: 10.2337/db18-1163. Epub 2019 Nov 22.

PMID:
31757794
2.

Does GLP-1 suppress its own basal secretion?

Elahi D, Ruff DA, Carlson OD, Meneilly GS, Habener JF, Egan JM.

Endocr Res. 2016;41(1):16-20. doi: 10.3109/07435800.2015.1038353. Epub 2015 Jul 17.

3.

Mechanisms of type 2 diabetes resolution after Roux-en-Y gastric bypass.

Elahi D, Galiatsatos P, Rabiee A, Salas-Carrillo R, Vakilipour A, Carlson OD, Angeli FS, Shannon RP, Egan JM, Andersen DK.

Surg Obes Relat Dis. 2014 Nov-Dec;10(6):1028-39. doi: 10.1016/j.soard.2014.07.011. Epub 2014 Aug 15.

PMID:
25443077
4.

Editorial: in praise of scientific review officers.

Elahi D, Mirmira RG, Kushner JA.

Mol Endocrinol. 2014 Jul;28(7):987-8. doi: 10.1210/me.2014-1179. No abstract available.

5.

GLP-1(32-36)amide, a novel pentapeptide cleavage product of GLP-1, modulates whole body glucose metabolism in dogs.

Elahi D, Angeli FS, Vakilipour A, Carlson OD, Tomas E, Egan JM, Habener JF, Shannon RP.

Peptides. 2014 Sep;59:20-4. doi: 10.1016/j.peptides.2014.06.004. Epub 2014 Jun 14.

6.

The glucoregulatory benefits of glucagon-like peptide-1 (7-36) amide infusion during intensive insulin therapy in critically ill surgical patients: a pilot study.

Galiatsatos P, Gibson BR, Rabiee A, Carlson O, Egan JM, Shannon RP, Andersen DK, Elahi D.

Crit Care Med. 2014 Mar;42(3):638-45. doi: 10.1097/CCM.0000000000000035.

7.

Hormonal response to a mixed-meal challenge after reversal of gastric bypass for hypoglycemia.

Lee CJ, Brown T, Magnuson TH, Egan JM, Carlson O, Elahi D.

J Clin Endocrinol Metab. 2013 Jul;98(7):E1208-12. doi: 10.1210/jc.2013-1151. Epub 2013 May 10.

8.

Raising serum gastrin to improve glycemic control in (type 2) diabetes: another limb of the enteroinsular axis?

Rickels MR, Elahi D.

J Clin Endocrinol Metab. 2012 Nov;97(11):3915-6. doi: 10.1210/jc.2012-3483. No abstract available.

PMID:
23129595
9.

Pancreatic polypeptide administration enhances insulin sensitivity and reduces the insulin requirement of patients on insulin pump therapy.

Rabiee A, Galiatsatos P, Salas-Carrillo R, Thompson MJ, Andersen DK, Elahi D.

J Diabetes Sci Technol. 2011 Nov 1;5(6):1521-8.

10.

Advances in the etiology and management of hyperinsulinemic hypoglycemia after Roux-en-Y gastric bypass.

Cui Y, Elahi D, Andersen DK.

J Gastrointest Surg. 2011 Oct;15(10):1879-88. doi: 10.1007/s11605-011-1585-8. Epub 2011 Jun 14. Review.

PMID:
21671112
11.

Effect of the dipeptidyl peptidase-4 inhibitor sitagliptin in older adults with type 2 diabetes mellitus.

Stafford S, Elahi D, Meneilly GS.

J Am Geriatr Soc. 2011 Jun;59(6):1148-9. doi: 10.1111/j.1532-5415.2011.03438.x. No abstract available.

PMID:
21668924
12.

Hyperinsulinemic hypoglycemia after Roux-en-Y gastric bypass: unraveling the role of gut hormonal and pancreatic endocrine dysfunction.

Rabiee A, Magruder JT, Salas-Carrillo R, Carlson O, Egan JM, Askin FB, Elahi D, Andersen DK.

J Surg Res. 2011 May 15;167(2):199-205. doi: 10.1016/j.jss.2010.09.047. Epub 2010 Oct 29.

13.

Diabetes and pancreatic cancer: chicken or egg?

Magruder JT, Elahi D, Andersen DK.

Pancreas. 2011 Apr;40(3):339-51. doi: 10.1097/MPA.0b013e318209e05d. Review.

PMID:
21412116
14.

Accuracy and reliability of the Nova StatStrip® glucose meter for real-time blood glucose determinations during glucose clamp studies.

Rabiee A, Magruder JT, Grant C, Salas-Carrillo R, Gillette A, DuBois J, Shannon RP, Andersen DK, Elahi D.

J Diabetes Sci Technol. 2010 Sep 1;4(5):1195-201.

15.

Impact of acute biochemical castration on insulin sensitivity in healthy adult men.

Rabiee A, Dwyer AA, Caronia LM, Hayes FJ, Yialamas MA, Andersen DK, Thomas B, Torriani M, Elahi D.

Endocr Res. 2010 May;35(2):71-84. doi: 10.3109/07435801003705601.

PMID:
20408755
16.

Numerical and clinical accuracy of a continuous glucose monitoring system during intravenous insulin therapy in the surgical and burn intensive care units.

Rabiee A, Andreasik V, Abu-Hamdah R, Galiatsatos P, Khouri Z, Gibson BR, Andersen DK, Elahi D.

J Diabetes Sci Technol. 2009 Jul 1;3(4):951-9.

17.

Glucose metabolism in burn patients: the role of insulin and other endocrine hormones.

Ballian N, Rabiee A, Andersen DK, Elahi D, Gibson BR.

Burns. 2010 Aug;36(5):599-605. doi: 10.1016/j.burns.2009.11.008. Epub 2010 Jan 13. Review.

PMID:
20074859
18.

Intensive insulin therapy confers a similar survival benefit in the burn intensive care unit to the surgical intensive care unit.

Gibson BR, Galiatsatos P, Rabiee A, Eaton L, Abu-Hamdah R, Christmas C, Milner SM, Andersen DK, Elahi D.

Surgery. 2009 Nov;146(5):922-30. doi: 10.1016/j.surg.2009.04.035. Epub 2009 Sep 5.

PMID:
19733884
19.

Clinical review: The extrapancreatic effects of glucagon-like peptide-1 and related peptides.

Abu-Hamdah R, Rabiee A, Meneilly GS, Shannon RP, Andersen DK, Elahi D.

J Clin Endocrinol Metab. 2009 Jun;94(6):1843-52. doi: 10.1210/jc.2008-1296. Epub 2009 Mar 31. Review.

20.

GLP-1 (9-36) amide, cleavage product of GLP-1 (7-36) amide, is a glucoregulatory peptide.

Elahi D, Egan JM, Shannon RP, Meneilly GS, Khatri A, Habener JF, Andersen DK.

Obesity (Silver Spring). 2008 Jul;16(7):1501-9. doi: 10.1038/oby.2008.229. Epub 2008 Apr 17.

21.

GLP-1 and appetite responses to a meal in lean and overweight adolescents following exercise.

Chanoine JP, Mackelvie KJ, Barr SI, Wong AC, Meneilly GS, Elahi DH.

Obesity (Silver Spring). 2008 Jan;16(1):202-4. doi: 10.1038/oby.2007.39.

22.

Effect of glucagon-like peptide-1 (GLP-1) on glycemic control and left ventricular function in patients undergoing coronary artery bypass grafting.

Sokos GG, Bolukoglu H, German J, Hentosz T, Magovern GJ Jr, Maher TD, Dean DA, Bailey SH, Marrone G, Benckart DH, Elahi D, Shannon RP.

Am J Cardiol. 2007 Sep 1;100(5):824-9. Epub 2007 Jun 14.

PMID:
17719327
23.

Ubiquitination is involved in glucose-mediated downregulation of GIP receptors in islets.

Zhou J, Livak MF, Bernier M, Muller DC, Carlson OD, Elahi D, Maudsley S, Egan JM.

Am J Physiol Endocrinol Metab. 2007 Aug;293(2):E538-47. Epub 2007 May 15.

24.

Effect of exenatide on beta cell function after islet transplantation in type 1 diabetes.

Ghofaili KA, Fung M, Ao Z, Meloche M, Shapiro RJ, Warnock GL, Elahi D, Meneilly GS, Thompson DM.

Transplantation. 2007 Jan 15;83(1):24-8.

PMID:
17220786
25.

Glucagon-like peptide-1 infusion improves left ventricular ejection fraction and functional status in patients with chronic heart failure.

Sokos GG, Nikolaidis LA, Mankad S, Elahi D, Shannon RP.

J Card Fail. 2006 Dec;12(9):694-9.

PMID:
17174230
26.

Regulation of appetite in lean and obese adolescents after exercise: role of acylated and desacyl ghrelin.

Mackelvie KJ, Meneilly GS, Elahi D, Wong AC, Barr SI, Chanoine JP.

J Clin Endocrinol Metab. 2007 Feb;92(2):648-54. Epub 2006 Nov 21.

PMID:
17119003
27.

Effect of glucagon-like peptide-1 (7-37) on beta-cell function after islet transplantation in type 1 diabetes.

Fung M, Thompson D, Shapiro RJ, Warnock GL, Andersen DK, Elahi D, Meneilly GS.

Diabetes Res Clin Pract. 2006 Nov;74(2):189-93. Epub 2006 Apr 18.

PMID:
16621111
28.

Pulsatile insulin secretion in elderly patients with diabetes.

Meneilly GS, Veldhuis JD, Elahi D.

Diabetes Res Clin Pract. 2006 Aug;73(2):218-20. Epub 2006 Apr 18.

PMID:
16621106
29.
30.

Peptide YY is secreted after oral glucose administration in a gender-specific manner.

Kim BJ, Carlson OD, Jang HJ, Elahi D, Berry C, Egan JM.

J Clin Endocrinol Metab. 2005 Dec;90(12):6665-71. Epub 2005 Sep 20.

PMID:
16174724
31.
32.

Active metabolite of GLP-1 mediates myocardial glucose uptake and improves left ventricular performance in conscious dogs with dilated cardiomyopathy.

Nikolaidis LA, Elahi D, Shen YT, Shannon RP.

Am J Physiol Heart Circ Physiol. 2005 Dec;289(6):H2401-8. Epub 2005 Jul 15.

33.

Relationship between testosterone levels, insulin sensitivity, and mitochondrial function in men.

Pitteloud N, Mootha VK, Dwyer AA, Hardin M, Lee H, Eriksson KF, Tripathy D, Yialamas M, Groop L, Elahi D, Hayes FJ.

Diabetes Care. 2005 Jul;28(7):1636-42.

PMID:
15983313
34.

Metabolic alterations in middle-aged and elderly lean patients with type 2 diabetes.

Meneilly GS, Elahi D.

Diabetes Care. 2005 Jun;28(6):1498-9. No abstract available.

PMID:
15920078
35.

Increasing insulin resistance is associated with a decrease in Leydig cell testosterone secretion in men.

Pitteloud N, Hardin M, Dwyer AA, Valassi E, Yialamas M, Elahi D, Hayes FJ.

J Clin Endocrinol Metab. 2005 May;90(5):2636-41. Epub 2005 Feb 15.

PMID:
15713702
36.

Glucagon-like peptide-1 limits myocardial stunning following brief coronary occlusion and reperfusion in conscious canines.

Nikolaidis LA, Doverspike A, Hentosz T, Zourelias L, Shen YT, Elahi D, Shannon RP.

J Pharmacol Exp Ther. 2005 Jan;312(1):303-8. Epub 2004 Sep 8.

PMID:
15356213
37.

Recombinant glucagon-like peptide-1 increases myocardial glucose uptake and improves left ventricular performance in conscious dogs with pacing-induced dilated cardiomyopathy.

Nikolaidis LA, Elahi D, Hentosz T, Doverspike A, Huerbin R, Zourelias L, Stolarski C, Shen YT, Shannon RP.

Circulation. 2004 Aug 24;110(8):955-61. Epub 2004 Aug 16.

PMID:
15313949
38.

Exendin-4 pharmacodynamics: insights from the hyperglycemic clamp technique.

Mager DE, Abernethy DR, Egan JM, Elahi D.

J Pharmacol Exp Ther. 2004 Nov;311(2):830-5. Epub 2004 Jun 15.

PMID:
15199095
39.

Effects of glucagon-like peptide-1 in patients with acute myocardial infarction and left ventricular dysfunction after successful reperfusion.

Nikolaidis LA, Mankad S, Sokos GG, Miske G, Shah A, Elahi D, Shannon RP.

Circulation. 2004 Mar 2;109(8):962-5. Epub 2004 Feb 23.

PMID:
14981009
40.

The development of myocardial insulin resistance in conscious dogs with advanced dilated cardiomyopathy.

Nikolaidis LA, Sturzu A, Stolarski C, Elahi D, Shen YT, Shannon RP.

Cardiovasc Res. 2004 Feb 1;61(2):297-306.

PMID:
14736546
41.

Effects of 3 months of continuous subcutaneous administration of glucagon-like peptide 1 in elderly patients with type 2 diabetes.

Meneilly GS, Greig N, Tildesley H, Habener JF, Egan JM, Elahi D.

Diabetes Care. 2003 Oct;26(10):2835-41.

PMID:
14514588
42.

Adiponectin levels do not change with moderate dietary induced weight loss and exercise in obese postmenopausal women.

Ryan AS, Nicklas BJ, Berman DM, Elahi D.

Int J Obes Relat Metab Disord. 2003 Sep;27(9):1066-71.

PMID:
12917712
43.

Plasma adiponectin and leptin levels, body composition, and glucose utilization in adult women with wide ranges of age and obesity.

Ryan AS, Berman DM, Nicklas BJ, Sinha M, Gingerich RL, Meneilly GS, Egan JM, Elahi D.

Diabetes Care. 2003 Aug;26(8):2383-8.

PMID:
12882866
44.

Effect of glucagon-like peptide 1 (7-36 amide) on insulin-mediated glucose uptake in patients with type 1 diabetes.

Meneilly GS, McIntosh CH, Pederson RA, Habener JF, Ehlers MR, Egan JM, Elahi D.

Diabetes Care. 2003 Mar;26(3):837-42.

PMID:
12610046
45.

Effects of 1-mo bolus subcutaneous administration of exendin-4 in type 2 diabetes.

Egan JM, Meneilly GS, Elahi D.

Am J Physiol Endocrinol Metab. 2003 Jun;284(6):E1072-9. Epub 2002 Dec 10.

46.

Biomarkers of caloric restriction may predict longevity in humans.

Roth GS, Lane MA, Ingram DK, Mattison JA, Elahi D, Tobin JD, Muller D, Metter EJ.

Science. 2002 Aug 2;297(5582):811. No abstract available.

47.

Glucagon-like peptide-1 augments insulin-mediated glucose uptake in the obese state.

Egan JM, Meneilly GS, Habener JF, Elahi D.

J Clin Endocrinol Metab. 2002 Aug;87(8):3768-73.

PMID:
12161508
48.

The insulinotropic effect of acute exendin-4 administered to humans: comparison of nondiabetic state to type 2 diabetes.

Egan JM, Clocquet AR, Elahi D.

J Clin Endocrinol Metab. 2002 Mar;87(3):1282-90.

PMID:
11889200
49.

Glucose tolerance, glucose utilization and insulin secretion in ageing.

Elahi D, Muller DC, Egan JM, Andres R, Veldhuist J, Meneilly GS.

Novartis Found Symp. 2002;242:222-42; discussion 242-6. Review.

PMID:
11855690
50.

Does waist circumference add to the predictive power of the body mass index for coronary risk?

Iwao S, Iwao N, Muller DC, Elahi D, Shimokata H, Andres R.

Obes Res. 2001 Nov;9(11):685-95.

Supplemental Content

Support Center